Eli Lilly (LLY) shares: returns by year and worst falls

Eli Lilly and Company · Health Care · number 9 in the S&P 500 by weight

Eli Lilly is an American maker of medicines, founded in 1876 in Indianapolis. Its largest products today treat diabetes and obesity; it also sells medicines for cancer, immune diseases and Alzheimer's disease.

Eli Lilly in numbers: returns and worst fall since 1972

$10,000 put into Eli Lilly in Jun 1972 and left alone was worth about $15,182,000 in Nov 2026. That is 14.4% a year over 54 years (LLY shares, total return).

The worst fall in that time was −68.3%, from the high in Aug 2000 to the low in Mar 2009. It was back at its old high in Oct 2014.

The best calendar year was 1997 (+93.5%), the worst was 1992 (−24.9%). 38 of 53 full years ended higher than they began.

Eli Lilly return by calendar year

2026 to Nov+26.5%
2025+40.2%
2024+33.3%
2023+60.9%
2022+34.3%
2021+66.1%
2020+31.0%
2019+16.1%
2018+40.5%
2017+17.8%
2016−10.4%
2015+25.4%
2014+39.8%
2013+7.3%
2012+24.2%
2011+25.2%
2010+3.7%
2009−6.2%
2008−21.3%
2007+5.7%
2006−5.2%
2005+2.5%
2004−17.5%
2003+13.1%
2002−17.6%
2001−14.4%
2000+41.9%
1999−24.2%
1998+29.1%
1997+93.5%
1996+32.7%
1995+77.3%
1994+15.6%
1993+2.4%
1992−24.9%
1991+17.0%
1990+9.5%
1989+64.1%
1988+12.8%
1987+7.5%
1986+36.8%
1985+75.7%
1984+19.8%
1983+5.1%
1982+7.6%
1981−8.3%
1980+11.2%
1979+29.4%
1978+30.8%
1977−17.4%
1976−5.5%
1975−22.8%
1974−6.8%
1973−6.2%

Buy and hold, total return, from daily closes of our own data, to Nov 2026. Past returns do not guarantee future results.

Growth of 100 since 1972

buy & hold · dividends reinvested · to 19 Nov 2026
Return a year
14.4%
since Jun 1972
Worst fall
−68.3%
Aug 2000 to Mar 2009
$10,000 became
$15,182,000
before taxes and costs
Drawdownfall from the previous high

Price history of LLY, adjusted for share splits and with dividends reinvested, in US dollars. Weekly points in the charts; the figures above are from daily closes.

Eli Lilly against the S&P 500, Jan 1993 to Nov 2026

Over these 34 years Eli Lilly returned 17.5% a year and the S&P 500 10.6% a year, both with dividends reinvested. The single share earned more, and the worst fall of Eli Lilly on the way was deeper: −68.3% against −55.2%.

Return a year$10,000 becameWorst fall
Eli Lilly LLY17.5%$2,331,000−68.3%
S&P 500 SPY10.6%$298,000−55.2%

The comparison starts in Jan 1993, the first month of our S&P 500 data. A past lead says nothing about the years ahead.

What drives Eli Lilly

Demand for its diabetes and obesity medicines and how fast it can make them is the main driver. Results of clinical trials, patent expiries, rules on drug prices and competition from other makers of weight-loss medicines matter as well.

What can go wrong with a single share

A drug maker depends on a small number of products. A failed trial, a safety finding or a price rule can change the picture quickly, and much growth is already expected in the share price.

One share or the whole index?

Whoever holds an S&P 500 fund already owns Eli Lilly: about $170 of every $10,000, next to 502 other stocks. A single company can do far better than the index for years and far worse for years, and nobody knows in advance which. That is the reason our systematic strategies follow whole markets and not single shares: the S&P 500, the Nasdaq-100 and 28 others, each reviewed once a month.

We have no strategy, no signal and no opinion on Eli Lilly shares. This page shows the public record so you can compare it with the index.

See how the strategies did on the S&P 500: free account

Questions about Eli Lilly shares

How much would $10,000 invested in Eli Lilly be worth today?

$10,000 put into Eli Lilly (LLY) in Jun 1972 and left alone, with dividends reinvested, was worth about $15,182,000 in Nov 2026. That is 14.4% a year over 54 years, before taxes and costs.

What was the worst fall of Eli Lilly shares?

The deepest fall since 1972 was 68.3%, from the high in Aug 2000 to the low in Mar 2009. The shares were back at their old high in Oct 2014.

Has Eli Lilly done better than the S&P 500?

From Jan 1993 to Nov 2026 Eli Lilly returned 17.5% a year with a worst fall of 68.3%. The S&P 500 returned 10.6% a year over the same time with a worst fall of 55.2%. Both with dividends reinvested. A past lead says nothing about the years ahead.

How big is Eli Lilly in the S&P 500?

Eli Lilly made up 1.74% of the S&P 500 on 19 Nov 2026, which made it number 9 of 503 stocks by weight. Of every $10,000 held in an S&P 500 fund, about $170 was Eli Lilly.

Does InvestWealth have a strategy for Eli Lilly shares?

No. Our systematic strategies follow whole markets, such as the S&P 500 that Eli Lilly is part of, not single shares. This page shows the public price history of Eli Lilly so that it can be compared with the index. It is not a recommendation to buy or sell.

Other companies

All 10 companies → · All 30 markets →

Educational research, not investment advice and not a recommendation to buy or sell any share. Past returns do not guarantee future results. Disclaimer.

Free · one email a month

Get the month-end letter

  • 30 markets after every month-end: what rose, what fell, and where each stands this year.
  • The main asset classes in one table, from stocks and bonds to gold and Bitcoin.
Free · no card · instant access · login details by email